Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.67 USD
Change Today -0.67 / -5.91%
Volume 60.2K
DRNA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 12:57 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Behlke M.D., Ph.D.

Co-Founder and Member of Scientific Advisory Board,Dicerna Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Mark Behlke, M.D, Ph.D. serves as Vice President of Molecular Genetics & Biophysics and Chief Scientific Officer of Integrated DNA Technologies and its Dicerna Scientific Co-founder. Dr. Behlke served as Vice President of Molecular Genetics & Biophysics for Integrated DNA Technologies (IDT) since 1996. He Co-Founded Dicerna Pharmaceuticals, Inc. He is the Co-Inventor of Dicerna's Dicer Substrate Technology. He serves as a Member of Scientific Advisory Board of Dicerna ...

Read Full Background

Corporate Headquarters*

87 Cambridgepark Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-621-8097
Fax: 617-612-6298

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Massachusetts Institute of Technology
PhD
Washington University, St. Louis
MD
Washington University, St. Louis

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRNA:US $10.67 USD -0.67

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive (leave of absence) and Director
Silence Therapeutics plc
200.0K GBP
J. Michael French Chairman, Chief Executive Officer and President
Marina Biotech, Inc.
$288.1K
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
A$400.0K
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
$707.1K
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Director
Arbutus Biopharma Corporation
$580.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DICERNA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.